US consumer groups allege misleading drug claims
BMJ 2001; 323 doi: https://doi.org/10.1136/bmj.323.7310.415 (Published 25 August 2001) Cite this as: BMJ 2001;323:415
- Scott Gottlieb
- New York
A coalition of US consumer groups has filed a lawsuit against Schering-Plough, the manufacturer of the allergy drug Claritin (loratadine), claiming that the company falsely advertises the benefits of the medicine.
The Boston based coalition, known as the Prescription Access Litigation project, filed a class action lawsuit accusing the drug manufacturer of misrepresenting Claritin in its advertising—causing increased demand for the drug—and of artificially inflating its price. The complaint alleges that Schering-Plough's advertising of the drug …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £173 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£38 / $45 / €42 (excludes VAT)
You can download a PDF version for your personal record.